Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Lu, Jian Ping ^a,b   Zhang, Jiao ^a   Kim, Kwonseop ^a,c   Case, Thomas C ^d   Matusik, Robert J ^d   Chen, Yan hua ^a   Wolfe, Michael ^e   Nopparat, Jongdee ^a   Lu, Qun ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c Chonnam National University   (South Korea)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; DELTA CATENIN; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DIPEPTIDE; E2F1 PROTEIN, HUMAN; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; N (N (3,5 DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT BUTYL ESTER; N-(N-(3,5-DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT-BUTYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; DROSOPHILA; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; METABOLISM; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CATENINS; CELL LINE, TUMOR; DIPEPTIDES; E2F1 TRANSCRIPTION FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MICE; MICROSCOPY, FLUORESCENCE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78549256780     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-304     Document Type: Article

References (35)

1. Paffenholz R, Franke WW. Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family. Differentiation 1997, 61:293-304. 10.1046/j.1432-0436.1997.6150293.x, 9342840.
2. Medina M, Marinescu RC, Overhauser J, Kosik KS. Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. Genomics 2000, 63:157-164. 10.1006/geno.1999.6090, 10673328.
3. Lu Q, Paredes M, Medina M, Zhou J, Cavallo R, Peifer M, Orecchio L, Kosik KS. delta-catenin, an adhesive junction-associated protein which promotes cell scattering. J Cell Biol 1999, 144:519-532. 10.1083/jcb.144.3.519, 2132907, 9971746.
4. Ho C, Zhou J, Medina M, Goto T, Jacobson M, Bhide PG, Kosik KS. delta-catenin is a nervous system-specific adherens junction protein which undergoes dynamic relocalization during development. J Comp Neurol 2000, 420:261-276. 10.1002/(SICI)1096-9861(20000501)420:2<261::AID-CNE8>3.0.CO;2-Q, 10753311.
5. Lu Q, Abdul A, Chen YH, Terrian DM, Gregory CW, Lanford GW. d-Catenin has the potential to promote the proliferation/survival and invasiveness of human cancer cells. Mol Biol Cell 2003, 14:341a.
6. Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S, Chen YH. Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer. Hum Pathol 2005, 36:1037-1048. 10.1016/j.humpath.2005.07.012, 16226102.
7. Lu Q, Zhang J, Allison R, Gay H, Yang WX, Bhowmick NA, Frelix G, Shappell S, Chen YH. Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate 2009, 69:411-418. 10.1002/pros.20902, 2633034, 19116988.
8. Zeng Y, Abdallah A, Lu JP, Wang T, Chen YH, Terrian DM, Kim K, Lu Q. delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles. Mol Cancer 2009, 8:19. 10.1186/1476-4598-8-19, 2660279, 19284555.
9. Wang T, Chen YH, Hong H, Zeng Y, Zhang J, Lu JP, Jeansonne B, Lu Q. Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer. Oncogene 2009, 28:555-564. 10.1038/onc.2008.399, 2678952, 18978817.
10. Kim K, Oh M, Ki H, Wang T, Bareiss S, Fini ME, Li D, Lu Q. Identification of E2F1 as a positive transcriptional regulator for delta-catenin. Biochem Biophys Res Commun 2008, 369:414-420. 10.1016/j.bbrc.2008.02.069, 2614404, 18302937.
11. Waghray A, Schober M, Feroze F, Yao F, Virgin J, Chen YQ. Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. Cancer Res 2001, 61:4283-4286.
12. Leong KG, Gao WQ. The Notch pathway in prostate development and cancer. Differentiation 2008, 76:699-716. 10.1111/j.1432-0436.2008.00288.x, 18565101.
13. Villaronga MA, Bevan CL, Belandia B. Notch signaling: a potential therapeutic target in prostate cancer. Curr Cancer Drug Targets 2008, 8:566-580. 10.2174/156800908786241096, 18991567.
14. Gupta A, Wang Y, Browne C, Kim S, Case T, Paul M, Wills ML, Matusik RJ. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells. Prostate 2008, 68:50-60. 10.1002/pros.20650, 18004726.
15. Hu Y, Ippolito JE, Garabedian EM, Humphrey PA, Gordon JI. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. J Biol Chem 2002, 277:44462-44474. 10.1074/jbc.M205784200, 12228243.
16. Strom A, Arai N, Leers J, Gustafsson JA. The Hairy and Enhancer of Split homologue-1 (HES-1) mediates the proliferative effect of 17beta-estradiol on breast cancer cell lines. Oncogene 2000, 19:5951-5953. 10.1038/sj.onc.1203990, 11127827.
17. Johansson T, Lejonklou MH, Ekeblad S, Stalberg P, Skogseid B. Lack of nuclear expression of hairy and enhancer of split-1 (HES1) in pancreatic endocrine tumors. Horm Metab Res 2008, 40:354-359. 10.1055/s-2008-1076695, 18491256.
18. Strom A, Castella P, Rockwood J, Wagner J, Caudy M. Mediation of NGF signaling by post-translational inhibition of HES-1, a basic helix-loop-helix repressor of neuronal differentiation. Genes Dev 1997, 11:3168-3181. 10.1101/gad.11.23.3168, 316755, 9389649.
19. Scorey N, Fraser SP, Patel P, Pridgeon C, Dallman MJ, Djamgoz MB. Notch signalling and voltage-gated Na+ channel activity in human prostate cancer cells: independent modulation of in vitro motility. Prostate Cancer Prostatic Dis 2006, 9:399-406. 10.1038/sj.pcan.4500894, 16832382.
20. Masumori N, Tsuchiya K, Tu WH, Lee C, Kasper S, Tsukamoto T, Shappell SB, Matusik RJ. An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line. J Urol 2004, 171:439-442. 10.1097/01.ju.0000099826.63103.94, 14665950.
21. Geling A, Steiner H, Willem M, Bally-Cuif L, Haass C. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 2002, 3:688-694. 10.1093/embo-reports/kvf124, 1084181, 12101103.
22. Breunig JJ, Silbereis J, Vaccarino FM, Sestan N, Rakic P. Notch regulates cell fate and dendrite morphology of newborn neurons in the postnatal dentate gyrus. Proc Natl Acad Sci USA 2007, 104:20558-20563. 10.1073/pnas.0710156104, 2154470, 18077357.
23. Kim H, Han JR, Park J, Oh M, James SE, Chang S, Lu Q, Lee KY, Ki H, Song WJ, Kim K. Delta-catenin-induced dendritic morphogenesis. An essential role of p190RhoGEF interaction through Akt1-mediated phosphorylation. J Biol Chem 2008, 283:977-987. 10.1074/jbc.M707158200, 2265781, 17993462.
24. Duparc RH, Boutemmine D, Champagne MP, Tetreault N, Bernier G. Pax6 is required for delta-catenin/neurojugin expression during retinal, cerebellar and cortical development in mice. Dev Biol 2006, 300:647-655. 10.1016/j.ydbio.2006.07.045, 16973151.
25. Zayzafoon M, Abdulkadir SA, McDonald JM. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. J Biol Chem 2004, 279:3662-3670. 10.1074/jbc.M308158200, 14602722.
26. Engin F, Bertin T, Ma O, Jiang MM, Wang L, Sutton RE, Donehower LA, Lee B. Notch Signaling Contributes to the Pathogenesis of Human Osteosarcomas. Hum Mol Genet 2009, 18:1464-1470. 10.1093/hmg/ddp057, 2733809, 19228774.
27. Zhang P, Yang Y, Zweidler-McKay PA, Hughes DP. Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008, 14:2962-2969. 10.1158/1078-0432.CCR-07-1992, 2830718, 18483362.
28. Weinmaster G. The ins and outs of notch signaling. Mol Cell Neurosci 1997, 9:91-102. 10.1006/mcne.1997.0612, 9245493.
29. Katoh M. Notch signaling in gastrointestinal tract (review). Int J Oncol 2007, 30:247-251.
30. Zhang Y, Lian JB, Stein JL, van Wijnen AJ, Stein GS. The Notch-responsive transcription factor Hes-1 attenuates osteocalcin promoter activity in osteoblastic cells. J Cell Biochem 2009, 108:651-659. 10.1002/jcb.22299, 19670267.
31. Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 2007, 19:649-657. 10.1016/j.ceb.2007.10.006, 2268988, 18032011.
32. Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DG. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol 1999, 19:6408-6414. 84610, 10454586.
33. Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, Rubin MA, Day ML. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Cancer Res 2006, 66:11897-11906. 10.1158/0008-5472.CAN-06-2497, 17178887.
34. Campbell WA, Iskandar MK, Reed ML, Xia W. Endoproteolysis of presenilin in vitro: inhibition by gamma-secretase inhibitors. Biochemistry 2002, 41:3372-3379. 10.1021/bi015810h, 11876645.
35. Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, Wolfe MS. Activity-dependent isolation of the presenilin-gamma-secretase complex reveals nicastrin and a gamma substrate. Proc Natl Acad Sci USA 2002, 99:2720-2725. 10.1073/pnas.052436599, 122414, 11867728.